Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsIntroduction of CHRNB4
Neuronal acetylcholine receptor subunit beta-4 is a protein encoded by the CHRNB4 gene with a molecule weight of 56 kDa. The CHRNB4 membrane protein has a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. This CHRNB4 membrane protein can be combined to alpha-2, alpha-3 or alpha-4 to give rise to functional receptors, like neuronal nicotinic acetylcholine receptor complex, alpha3-alpha6-beta4.
| Basic Information of CHRNB4 | |
| Protein Name | Neuronal acetylcholine receptor subunit beta-4 |
| Gene Name | CHRNB4 |
| Aliases | |
| Organism | Homo sapiens (Human) |
| UniProt ID | P30926 |
| Transmembrane Times | 4 |
| Length (aa) | 498 |
| Sequence | MRRAPSLVLFFLVALCGRGNCRVANAEEKLMDDLLNKTRYNNLIRPATSSSQLISIKLQLSLAQLISVNEREQIMTTNVWLKQEWTDYRLTWNSSRYEGVNILRIPAKRIWLPDIVLYNNADGTYEVSVYTNLIVRSNGSVLWLPPAIYKSACKIEVKYFPFDQQNCTLKFRSWTYDHTEIDMVLMTPTASMDDFTPSGEWDIVALPGRRTVNPQDPSYVDVTYDFIIKRKPLFYTINLIIPCVLTTLLAILVFYLPSDCGEKMTLCISVLLALTFFLLLISKIVPPTSLDVPLIGKYLMFTMVLVTFSIVTSVCVLNVHHRSPSTHTMAPWVKRCFLHKLPTFLFMKRPGPDSSPARAFPPSKSCVTKPEATATSTSPSNFYGNSMYFVNPASAASKSPAGSTPVAIPRDFWLRSSGRFRQDVQEALEGVSFIAQHMKNDDEDQSVVEDWKYVAMVVDRLFLWVFMFVCVLGTVGLFLPPLFQTHAASEGPYAAQRD |
Function of CHRNB4 Membrane Protein
Neuronal acetylcholine receptor subunit beta-4 is ubiquitously present on airway epithelial cells and forms heteromeric nAchRs to modulate receptor affinity for nicotine. Genome-wide association studies have revealed that chromosome region 15q25, which harbors the CHRNB4 gene, is associated with an increased risk for nicotine dependence in European, American and Asian populations. Beyond that, CHRNB4 is strongly associated with genetic lung cancer susceptibility variants and a functional impact on tumorigenic potential. Two contradicting findings report that CHRNB4 plays a potential tumor suppressor or oncogenic role in lung cancer. Therefore, it is conceivable that the role of CHRNB4 in lung cancer is diverse, depending on the cellular subtypes or tumor stages.
Fig.1 Evidence supporting the repurposing of bupropion for smoking cessation. This figure shows the 10 most supportive paths (out of 365 total) for treating nicotine dependence with bupropion, as available in this prediction’s Neo4j Browser guide. (Himmelstein, 2017)
Application of CHRNB4 Membrane Protein in Literature
This article finds that epigenetic regulation of CHRNB4 may affect tumor progression and survival in patients with NSCLC.
This article suggests that two previously reported variants Tyr215Tyr and Asp398Asn of CHRNA3-CHRNA5-CHRNB4 and a novel exon variant Ser140Gly are significantly related to COPD risk in Chinese. These variants may be genetic biomarkers for predicting COPD risk in Chinese.
This article suggests the importance of SNP rs1948 on the regulation of CHRNB4 expression and provides the first evidence of CHRNB4 down-regulation by miR-138.
This article reveals that variants in the CHRNA5-CHRNA3-CHRNB4 region identify individuals at increased risk of cessation failure, and this increased risk can be ameliorated by cessation pharmacotherapy.
This article suggests that CHRNB4 is strongly associated with genetic lung cancer susceptibility variants and a functional impact on tumorigenic potential.
CHRNB4 Preparation Options
Membrane protein studies have advanced significantly over the past few years. Based on our versatile Magic™ membrane protein production platform, we could offer a series of membrane protein preparation services for worldwide customers in reconstitution forms as well as multiple active formats. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-CHRNB4 antibody development services.
During the past years, Creative Biolabs has successfully generated many functional membrane proteins for our global customers. We are happy to accelerate the development of our clients’ programs with our one-stop, custom-oriented service. For more detailed information, please feel free to contact us.
Reference
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
